News | February 02, 2012

Aria Health First on East Coast to Use Epoch System to Treat Arrhythmias

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D.,

Aria Health electrophysiologists (from left to right) Roger A. Marinchak, M.D., FACC Scott Spielman, M.D., FACC and Bradley Bacik, DO, FACC, are the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System, to perform robotic ablation of heart arrhythmias.


February 2, 2012 — Aria Health, the largest healthcare provider in Northeast Philadelphia and Bucks County, is the first on the East Coast to utilize Epoch, the latest generation of the Stereotaxis Magnetic Navigation System. This innovative technology allows electrophysiologists to treat many types of cardiac arrhythmias, or heart rhythm disorders, with robotic-driven catheter ablation procedures.

Housed in the heart center at Aria Health’s Torresdale Campus, Epoch offers many advantages over conventional treatment methods, according to Scott Spielman, M.D., FACC, director of Aria’s electrophysiology laboratory.

"Standard catheters used for ablation are fairly stiff, making them difficult to guide and raising the risk of perforating heart tissue,” said Spielman.  “The Epoch system employs a soft, floppy catheter which enables us to complete procedures in a shorter time period with greater safety.”

The new system reduces patient radiation exposure by two-thirds, and is effective for treating ventricular arrhythmias as well as other types of abnormal heart rhythms.

“This allows us to get a catheter tip to sites inside the complex internal anatomy with less force and more precision,” said Roger Marinchak, M.D., FACC, an electrophysiologist at Aria Health.  “This causes less risk of causing perforation injury to structures that one doesn’t want to ablate or hurt."

As the United States population ages, the number of people with atrial fibrillation (AF) - the most common type of serious arrhythmia - will grow, says Aria electrophysiologist Bradley Bacik, DO, FACC. While AF is a chronic condition that cannot be cured, he adds, ablation treatments available at Aria Health can substantially reduce symptoms.

For more information: www.ariahealth.org


Related Content

News

Oct. 24, 2024 — Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera ...

Home October 30, 2024
Home
News

Oct. 18, 2024 — Boston Scientific Corp. recently announced it has received U.S. Food and Drug Administration (FDA) ...

Home October 21, 2024
Home
News

May 15, 2024 —CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for cardiac ...

Home May 15, 2024
Home
News

May 13, 2024 — Innovative Health, Inc. announced that recent growth in single-use device reprocessing has delivered ...

Home May 13, 2024
Home
News

October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...

Home October 10, 2023
Home
News

August 9, 2023 — Boston Scientific Corporation announced it has received U.S. Food and Drug Administration (FDA) ...

Home August 09, 2023
Home
News

January 31, 2023 —Imricor, a global leader in real-time interventional cardiac magnetic resonance (iCMR) ablation ...

Home January 31, 2023
Home
News

December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...

Home December 21, 2022
Home
News

October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...

Home October 24, 2022
Home
News

May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...

Home May 13, 2022
Home
Subscribe Now